Navigation Links
Pharmasset Reports Fiscal Second Quarter 2011 Financial Results
Date:4/25/2011

merase, thus inhibiting viral replication. We currently have three clinical-stage product candidates. PSI-7977, an unpartnered uracil nucleotide analog that is currently dosing in three Phase 2b studies in patients with HCV genotypes 1 through 6 and PSI-938, an unpartnered guanosine nucleotide analog which recently completed a 14-day monotherapy study and a 14-day combination study with PSI-7977. RG7128, a cytosine nucleoside analog for chronic HCV infection, is in two Phase 2b clinical studies in combination with Pegasys® plus Copegus® and one interferon free combination trial. These clinical studies are being conducted through a strategic collaboration with Roche.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Forward-Looking StatementsPharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:  Statements in this press release that are not historical facts are "forward-looking statements," that involve risks, uncertainties, and other important factors, including, without limitation,  the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates,  the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized.  For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 and our Quarterly Reports on Form 10-Q filed with the Securities an
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... -- Reportlinker.com announces that a new market research report ... Eastern Europe 2014 http://www.reportlinker.com/p02312454/Baby-Food-Eastern-Europe-2014.html ... a new report by ERC that analyzes the Baby ... , key segments, features & developments, future projections ... which are currently affecting the industry. Furthermore, it profiles ...
(Date:8/27/2014)... Aug. 27, 2014 North American lighting leader ... 100 Award for the new OSRAM ITOS ® PHASER ... light module for microscopy, endoscopy and surgical head lamps that ... higher efficacy and lamp life. "We,re honored to ... the most innovative new technologies of the past year," said ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... , BASKING RIDGE, N.J., Nov. 11 Regado ... of antithrombotic aptamers with active control agents, announced ... Chief Scientific Officer, will be presenting an abstract ... Center in Philadelphia, Pennsylvania. Dr. Rusconi,s abstract "Aptamer-Active ...
... Recap LLC (Recap) has launched "Development Optimizer," the ... Deloitte. The series of biopharmaceutical business intelligence tools ... toward business development, corporate strategy, financial, clinical development, ... Optimizer" provides flexible analytical tools for biopharmaceutical executives ...
Cached Medicine Technology:Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009 2Deloitte Recap Launches New Solution for Clinical Development 2Deloitte Recap Launches New Solution for Clinical Development 3
(Date:8/27/2014)... 2014 With most forms of ... to use hearing protection when exposed to loud ... many different forms of hearing protection ... hearing protection training and devices for workers in ... The National Institute of Occupational Safety and Health ...
(Date:8/27/2014)... significantly improve musculoskeletal and overall health, and minimize or ... of the latest research on senior athletes (ages 65 ... Journal of the American Academy of Orthopaedic Surgeons ... aging causes an inevitable deterioration of the body and ... of related injuries such as sprains, strains and fractures; ...
(Date:8/27/2014)... August 27, 2014 For nearly two ... by the beloved mantra singers Deva Premal & Miten ... the release of their latest album in May, their ... in twenty-two countries around the globe, including Russia, Ukraine, ... and across Europe. With a new album and a ...
(Date:8/27/2014)... positive hospital blood culture samples are discarded every day ... skin germs instead of specific disease-causing bacteria. , ... clinicians may be able to use the resistance profiles ... patients with antibiotics appropriate to their ailment, Tel Aviv ... Alon of TAU,s Sackler Faculty of Medicine and the ...
(Date:8/27/2014)... New York (PRWEB) August 27, 2014 ... by Transparency Market Research "Ablation Technologies Market (Applications: ... Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global ... 2014 - 2020," the global ablation technologies market ... and is estimated to reach a market worth ...
Breaking Medicine News(10 mins):Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 2Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 3Health News:Lifetime of fitness: A fountain of youth for bone and joint health? 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:'Junk' blood tests may offer life-saving information 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5
... Va., Dec. 3 Allergy & Asthma Network,Mothers ... Web-based video,geared to help people successfully manage the ... now available at its Web site, www.breatherville.org . ... technology that,allows viewers to ask questions in everyday ...
... strong associations with hypertension, cardiovascular disease, and diabetes, ... and structure, according to a new study accepted ... of Clinical Endocrinology & Metabolism ( JCEM ... of a direct or strong correlation of obesity ...
... long-term, common sense approach to dieting. , ... San ... trusted, independent source for comparing the most valuable Internet services, is ... Guide," a free guide filled with useful advice for those ...
... Group,s Military Hiring Conferences are avenues for companies seeking former military ... give progressive companies an opportunity to proactively interview the U.S. Military,s ... ... Lucas Group, an executive recruitment search firm, announces its Military Hiring ...
... a nationally accredited provider of psychology, counseling ... 1992, has launched its long-awaited new website ... complete CE courses online on a seamless ... most states are required to maintain their ...
... using a novel, hand-operated robotic device and functional MRI ... rehabilitated, according to a study presented today at the ... (RSNA). This is the first study using fMRI to ... , "We have shown that the brain has the ...
Cached Medicine News:Health News:AANMA Announces Launch of Free Web-Based Education Program for Patients Transitioning From CFC to HFA Inhalers 2Health News:Pediatric obesity may alter thyroid function and structure 2Health News:NextAdvisor.com Launches "Lose the Weight this Year: A Common Sense Dieter's Guide" 2Health News:Lucas Group Announces Their Executive Recruitment Military Hiring Conference Schedule for December 2008 2Health News:Lucas Group Announces Their Executive Recruitment Military Hiring Conference Schedule for December 2008 3Health News:Revolutionary New Learning Website Makes Continuing Education a Pleasure 2Health News:Revolutionary New Learning Website Makes Continuing Education a Pleasure 3Health News:Revolutionary New Learning Website Makes Continuing Education a Pleasure 4Health News:Robotic technology improves stroke rehabilitation 2
Small, removable blades, length 178 mm, (7"). Function: tissue retracting....
Toothed Pituitary IVD Rongeurs, 8 length 200 mm....
... Pin is the first skull pin to utilize cutting ... of crushing its way into bone the Hifix pin ... viable providing improved initial fixation over standard skull pins. ... crown with Hifix pins and in the bremer 3D ...
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Medicine Products: